Anaphylaxis causes distributive shock, one of four broad categories of shock recognized in medicine. In distributive shock, blood vessels dilate so widely and become so leaky that blood pressure plummets, even though the heart itself is still pumping. This makes anaphylactic shock fundamentally different from shock caused by blood loss or heart failure, and it explains why the treatment is so specific.
Why It’s Called Distributive Shock
The four main types of shock are hypovolemic (from fluid or blood loss), cardiogenic (from heart pump failure), obstructive (from a physical blockage like a blood clot in the lungs), and distributive (from widespread blood vessel dilation). Distributive shock is sometimes called vasodilatory shock because the core problem is that blood vessels relax and widen so dramatically that the circulatory system can no longer maintain adequate pressure.
Anaphylaxis shares this category with septic shock (caused by severe infection) and neurogenic shock (caused by spinal cord injury). All three involve a dangerous drop in the resistance blood vessels normally provide. The difference is speed. Septic shock typically develops over hours as an infection spirals. Anaphylactic shock can hit within seconds to minutes of exposure to an allergen, making it the fastest-onset form of distributive shock.
What Happens Inside Your Blood Vessels
When your immune system identifies an allergen as a serious threat, it triggers specialized immune cells called mast cells to dump their contents into the bloodstream all at once. The most important of these chemicals is histamine, but mast cells also release prostaglandins and other inflammatory compounds. Together, these substances do two things simultaneously: they force blood vessels to relax and widen, and they make the walls of tiny blood vessels (capillaries) far more permeable than normal.
That permeability is what makes anaphylactic shock so dangerous. Fluid that should stay inside the bloodstream leaks out into surrounding tissues. Up to 35% of your blood volume can shift out of the vascular system and into surrounding tissue within just 10 minutes. This is why people in anaphylaxis can develop dramatic swelling, hives, and a puffy face while simultaneously losing blood pressure. The heart is still beating, but it has far less fluid to pump, and the vessels it’s pumping into have lost their tone. The result is a rapid, severe drop in blood pressure.
How Blood Pressure Drops During Anaphylaxis
Clinically, anaphylactic shock is defined by specific blood pressure thresholds. In adults, a systolic reading below 90 mm Hg or a drop of more than 30% from baseline qualifies. In children, the threshold is an age-specific low systolic pressure or the same 30% drop. These numbers can be reached alarmingly fast after exposure to a trigger, sometimes within minutes.
The blood pressure collapse in anaphylaxis feels different from fainting or dehydration. Because the reaction affects nearly every organ system at once, the drop in blood pressure usually comes alongside other symptoms: skin flushing or hives, throat tightness, wheezing, nausea, or a sense of impending doom. That combination of cardiovascular collapse plus skin and respiratory symptoms is what distinguishes anaphylactic shock from other causes of sudden low blood pressure.
Why Epinephrine Is the First-Line Treatment
Because anaphylactic shock is driven by blood vessel dilation and fluid leakage, the treatment targets those exact problems. Epinephrine (the medication in auto-injectors like EpiPen) directly counteracts what histamine is doing. It tightens blood vessels back up, raises blood pressure, opens the airways, and slows the further release of inflammatory chemicals from mast cells. No other medication addresses all of these problems simultaneously, which is why epinephrine is the only first-line treatment for anaphylaxis.
The standard dose for adults and children weighing 30 kilograms (about 66 pounds) or more is 0.3 mg, injected into the outer thigh. The thigh is the preferred site because epinephrine reaches peak blood levels significantly faster when injected into the large muscle there compared to the upper arm, whether given into the muscle or under the skin. In a situation where seconds matter, that speed difference can be clinically meaningful. The injection can be repeated every 5 to 10 minutes if symptoms don’t improve.
How Anaphylactic Shock Differs From Other Shock Types
Understanding the category helps explain why treatments differ so much across shock types. In hypovolemic shock, the problem is simple volume loss from bleeding or dehydration, so the fix is replacing fluid. In cardiogenic shock, the heart muscle itself is failing, so treatment focuses on supporting or restarting the pump. In anaphylactic shock, neither the heart nor the blood volume was the original problem. The blood vessels themselves betrayed the system by dilating and leaking, all because of a misdirected immune response.
This is why giving IV fluids alone won’t reverse anaphylaxis. Fluids help, but without epinephrine to constrict the blood vessels and seal the capillary walls, the fluid just leaks out again. It’s also why antihistamines, while helpful for hives and itching, are not adequate treatment for anaphylactic shock on their own. They block some of the histamine effects but cannot reverse the cardiovascular collapse quickly enough.
The Risk of a Second Wave
One feature of anaphylactic shock that catches people off guard is the possibility of a biphasic reaction, where symptoms resolve and then return hours later without any new allergen exposure. The average time between the initial reaction resolving and the second wave varies widely across studies, ranging from 1 to 72 hours, with most studies reporting a mean onset greater than 8 hours. While the overall incidence is low, it’s unpredictable enough that people who experience anaphylaxis are typically monitored for several hours afterward, even if they feel completely recovered after epinephrine.
The second wave involves the same distributive shock mechanism as the first. Residual inflammatory chemicals, or a delayed release from mast cells, can restart the cascade of vessel dilation and fluid leakage. This is why carrying two auto-injectors is standard advice for anyone at risk of anaphylaxis, and why the initial recovery doesn’t necessarily mean the event is over.